RxDoctor Payments Data

Guang Yang, MD

Physical Medicine & Rehabilitation · Fairlawn, OHNPI 1396767612

Payments from drug & device makers

$987in general payments, 2019–2025

Across 53 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Averitas Pharma Inc.$250
  • AbbVie$207
  • Collegium Pharmaceutical, Inc.$201
  • Globus Medical$130
  • GRT US Holding, Inc.$64
  • Si-bone, Inc.$41
  • plus $93 from 4 others

What the payments were for

  • Food & beverage$987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$987 in reported general payments places this provider in the 70th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio

Medicare billing

Part B allowed, 2024
$309,029
Medicare patients
621
Services billed
8,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen671$14,779
Buprenorphine59$10,832
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen512$9,186
BelbucaBuprenorphine Hcl13$5,886
Gabapentin403$4,783
Pregabalin233$4,293
Lidocaine46$3,342
Diclofenac Sodium174$3,293
Fentanyl40$2,846
Tizanidine Hcl264$2,696
Morphine Sulfate ErMorphine Sulfate65$2,046
Cyclobenzaprine Hcl208$1,852
Celecoxib111$1,368
Methocarbamol88$1,339
Tramadol Hcl228$1,325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$201$5,88613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 332 physical medicine & rehabilitation providers in Ohio.

Other physical medicine & rehabilitation in Fairlawn

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →